ScreenerHero

TELO Telomir Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · telomirpharma.com
1.200USD-0.83%Mkt Cap: 82.53M $P/E: —

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INSM
Insmed Incorporated
$22.98BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap82.53M USD
Enterprise Value77.50M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.41M USD
Revenue/Share—
Last Price1.200 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.29
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B16.44
EPS (TTM)-1.11
EPS (Forward)-0.28
52W Range
0.888526% of range2.091
52W High2.091 USD
52W Low0.8885 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-176.10%
ROA-141.84%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.69M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-3.72%
Net Debt-5.03M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity2.72
Current Ratio16.14
Quick Ratio15.55
Book Value/Sh0.07 USD
Cash/Share0.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.000 USD
Upside (mean)+233.3%
Target Range4.000 USD – 4.000 USD
# Analysts1
Ownership
Shares Out.68.77M
Float37.14M
Insiders46.00%
Institutions4.31%
Short Interest
Short Ratio15.7d
Short % Float1.76%
Short % Out.1.13%
Shares Short777.08K
Short (prev mo.)813.87K
Technical
SMA 501.169 (+2.6%)
SMA 2001.255 (-4.4%)
Beta-0.30
S&P 52W Chg16.45%
Avg Vol (30d)108.01K
Avg Vol (10d)64.28K
Technical Indicators
RSI (14)52.0
MACD0.0079
MACD Signal0.0090
MACD Hist.-0.0010
BB Upper1.247 USD
BB Middle1.194 USD
BB Lower1.142 USD
BB Width8.86%
ATR (14)0.0907 USD
Vol Ratio (20d)16.57x